Brightbeam.
We are not a generalist AI consultancy. The methodology, the team, the regulatory posture and the security stance are documented here for the people who need to assess whether Brightbeam is a defensible partner.
Global organisations currently working with Brightbeam.
Awards won in the last two years.
Content validity of the CTA-derived research across NRC, CIA and NASA applications.
We think. We build. We embed.
To be the most helpful company in the world.
Brightbeam embeds digital intelligence into the operating models of regulated organisations. We use frontier AI and other technologies to build the capability inside organisations that turns digital intelligence into an operating principle.
Our work spans biopharma, medtech, financial services, advanced manufacturing and adjacent regulated sectors. The medtech programme documented on this site is a sector-specific application of a broader curriculum and methodology that has been refined across hundreds of cohorts.
The discipline that defines our work – the reason organisations come back for second and third sprints – is sustained focus on the operating model rather than the technology. AI tools change every quarter. The patterns of how they are used safely inside regulated work change much more slowly. Those patterns are what we teach.
Three pieces of intellectual heritage. Equal weight.
The Brightbeam approach is built on three pieces of intellectual heritage that distinguish it from generic AI training. None is ours. All are operationalised.
Schelling Point coordination.
Enterprise AI adoption is a coordination problem, not just an information problem. Most training programmes treat it as the latter and produce competent individuals who never converge into collective practice.
The discipline is the deliberate engineering of the conditions under which a focal point – a coordination point everyone gravitates toward without being told – actually forms. The Embed programme works to develop five conditions in parallel: reduced options, shared mental models, common knowledge, group identity and visible early adopters. This is how to engineer gravity.
Cognitive Task Analysis.
CTA is the discipline of capturing how experienced practitioners actually make decisions in complex, time-pressured, high-stakes environments. We do not own the methodology. We operationalise it.
The medtech curriculum is grounded in CTA-derived task analysis of the work medtech professionals actually do, validated at 92–94% content validity across NRC, CIA and NASA applications of the underlying research.
The judgement layer.
Brightbeam's Embed programme is the judgement layer of AI-native services for regulated industries. The captured judgement of experienced practitioners – what they look for, what they refuse to do, where they pause, how they explain their decisions – is the substance the curriculum teaches participants to extract, encode and operationalise.
AI provides the capability. The judgement layer makes that capability defensible.
Data sensitivity is foundational to delivery, not bolted on.
Brightbeam treats data sensitivity as foundational to delivery. The relevant elements of our security and data posture for medtech engagements:
We work primarily with the AI tools the client has already approved or is prepared to approve. We do not require new tool deployments for delivery. Where new tools are introduced, they go through the client's existing IT and security approval process.
No PHI is used in worked examples. They use anonymised or synthetic data drawn from sector-appropriate sources.
Client-confidential material – internal SOPs, prior submissions, supplier-confidential data – is handled inside the client's controlled environments. Where Brightbeam needs access to client material for worked-example preparation, it is governed by the engagement's data processing agreement.
Where engagements span jurisdictions, GDPR adequacy, Schrems II and equivalent considerations are factored into tool selection and data handling at the Plan stage.
All security and data handling decisions made during the engagement are documented and available to the client for inclusion in their own audit trail.
A full security and data handling pack is available through the contact in the footer for procurement and IT review.
What we don't claim.
Brightbeam's posture on regulated AI use is documented in detail across the site – particularly in Why Embed, Why Now and inside the Foundations module. The summary, for the purposes of this page:
Regulatory endorsement.
No regulator has approved, certified or endorsed Brightbeam's curriculum or methodology. The curriculum is designed to help organisations meet their regulatory obligations; meeting those obligations is the organisation's responsibility, not Brightbeam's.
A substitute for your QMS.
The curriculum does not substitute for any organisation's quality system, training records, validated systems or regulatory affairs function. It operates alongside those structures and is designed to embed AI use into them rather than around them.
Treat monitoring as discipline.
The regulatory context inside the curriculum is refreshed within thirty days of any material change to the EU AI Act, MDR, IVDR, FDA AI/ML guidance, MHRA software guidance, IMDRF positions or HPRA-specific developments.
The substance of the curriculum is in The Curriculum. The methodology is in Our Approach. The practical delivery detail is in How We Deliver. The outcomes are in Outcomes. This page covers the foundations underneath all of them.
Specific procurement, IT, legal or regulatory questions live in the FAQ, organised by audience.
Talk to James Harte →This site is not a brochure or a sign-up funnel. It exists so that you can answer your own questions – and those of colleagues helping to decide whether you need an embed training programme.
Our full curriculum is here. The methodology behind it is here. The measurement framework is here. The answers to every generic question we get asked, organised by who is asking, are here.
What you will not find: marketing fluff, gated content, lead-capture forms, vague claims, or anything we cannot substantiate.